Anne Szarewski

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. doi request reprint HPV vaccination and cervical cancer
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and The London School of Medicine and Dentistry Charterhouse Square, London EC1M 6BQ, UK
    Curr Oncol Rep 14:559-67. 2012
  2. doi request reprint Women's attitudes towards monthly bleeding: results of a global population-based survey
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, London, UK
    Eur J Contracept Reprod Health Care 17:270-83. 2012
  3. doi request reprint Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK
    Expert Rev Vaccines 11:645-57. 2012
  4. pmc Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, London, United Kingdom
    J Clin Microbiol 50:1867-73. 2012
  5. doi request reprint Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
    A Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
    Int J Cancer 131:106-16. 2012
  6. doi request reprint 50 years of "The Pill": celebrating a golden anniversary
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, UK
    J Fam Plann Reprod Health Care 36:231-8. 2010
  7. pmc HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
    A Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK
    Br J Cancer 104:915-20. 2011
  8. doi request reprint HPV vaccine: Cervarix
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, UK
    Expert Opin Biol Ther 10:477-87. 2010
  9. doi request reprint Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
    J Med Screen 16:193-8. 2009
  10. doi request reprint Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study
    Jack Cuzick
    Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary s School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom
    Int J Cancer 122:2294-300. 2008

Collaborators

Detail Information

Publications22

  1. doi request reprint HPV vaccination and cervical cancer
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and The London School of Medicine and Dentistry Charterhouse Square, London EC1M 6BQ, UK
    Curr Oncol Rep 14:559-67. 2012
    ..Adolescent girls remain the primary target of vaccination programmes, but the issues of vaccinating boys and older women are increasingly debated...
  2. doi request reprint Women's attitudes towards monthly bleeding: results of a global population-based survey
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, London, UK
    Eur J Contracept Reprod Health Care 17:270-83. 2012
    ..Objective: Monthly bleeding can be uncomfortable and inconvenient. Fifty years after the introduction of the pill, one wonders whether women still want to bleed every month...
  3. doi request reprint Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK
    Expert Rev Vaccines 11:645-57. 2012
    ..The vaccine's antibody response profile suggests a long duration of immunity. Safety data have been reassuring, which is not unexpected, given that the vaccine is composed of virus-like particles, rather than being a live-virus vaccine...
  4. pmc Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, London, United Kingdom
    J Clin Microbiol 50:1867-73. 2012
    ..7% PPV. Our study confirms that, in a referral setting, HPV testing by a number of different tests provides high sensitivity for high-grade disease. Further work is needed to confirm these findings in a routine screening setting...
  5. doi request reprint Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
    A Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
    Int J Cancer 131:106-16. 2012
    ..The vaccine did not impact the outcome of HPV-16/18 infections present at the time of vaccination. Vaccination was generally well tolerated regardless of the woman's HPV-16/18 DNA or serological status at entry...
  6. doi request reprint 50 years of "The Pill": celebrating a golden anniversary
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, UK
    J Fam Plann Reprod Health Care 36:231-8. 2010
    ..This article summarises the advances in oral contraceptives over time and describes the most current clinical data regarding the use of COCs...
  7. pmc HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
    A Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK
    Br J Cancer 104:915-20. 2011
    ....
  8. doi request reprint HPV vaccine: Cervarix
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, UK
    Expert Opin Biol Ther 10:477-87. 2010
    ..Vaccination against the human papillomavirus (HPV), which is the major cause of cervical cancer, is a significant step forward...
  9. doi request reprint Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
    J Med Screen 16:193-8. 2009
    ..We explored Muslim women's attitudes to self-sampling for human papillomavirus (HPV) in the context of cervical cancer screening and their responses to two self-sampling devices...
  10. doi request reprint Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study
    Jack Cuzick
    Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary s School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom
    Int J Cancer 122:2294-300. 2008
    ..52, p = 0.001), whereas there was little difference according to initial cytology (HR = 1.64, p = 0.51)...
  11. doi request reprint Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears
    Jack Cuzick
    Wolfson Institute of Preventive Medicine, Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Queen Mary University of London, London, United Kingdom
    J Med Virol 82:1186-91. 2010
    ..Differences between these tests appeared to be related mostly to the choice of cutoff level. An added feature of the Abbott test was the provision of type specific results for HPV 16 and 18...
  12. doi request reprint Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, United Kingdom
    Cancer Epidemiol Biomarkers Prev 17:3033-42. 2008
    ..This study compared the sensitivity and specificity of several adjunctive tests for the detection of high-grade CIN in a population referred to colposcopy because of abnormal cytology...
  13. doi request reprint Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities
    David Mesher
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK
    Eur J Cancer 49:2179-86. 2013
    ..To compare triage strategies using different human papillomavirus (HPV) consensus and genotyping tests and a p16(INK4a) test...
  14. ncbi request reprint Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
    J Med Screen 14:34-42. 2007
    ..To compare the performance and acceptability of unsupervised self-sampling with clinician sampling for high-risk human papillomavirus (HPV) types for the first time in a UK screening setting...
  15. ncbi request reprint Overview of the European and North American studies on HPV testing in primary cervical cancer screening
    Jack Cuzick
    Cancer Research UK, Wolfson Institute of Preventive Medicine, London
    Int J Cancer 119:1095-101. 2006
    ..These results support the use of HPV testing as the sole primary screening test, with cytology reserved for women who test HPV positive. Large demonstration projects are needed to fully evaluate this strategy...
  16. doi request reprint New technologies and procedures for cervical cancer screening
    Jack Cuzick
    Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
    Vaccine 30:F107-16. 2012
    ..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
  17. pmc Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study
    Louise Cadman
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Bart s and the London School of Medicine, London, UK
    J Fam Plann Reprod Health Care 38:214-20. 2012
    ..To explore self-reported cervical screening history and barriers to attendance among women who have been sexually abused and to identify measures to improve the experience of cervical screening for these women...
  18. doi request reprint Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males
    Sara L Bissett
    Virus Reference Department, Centre for Infections, Health Protection Agency, London, United Kingdom
    J Med Virol 83:1744-51. 2011
    ..The utility of urine for type-specific detection in males is less certain...
  19. pmc Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation
    Anne Szarewski
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom
    J Infect Dis 208:1391-6. 2013
    ..A post hoc analysis of the phase III PATRICIA (PApilloma TRIal against Cancer In young Adults) trial (NCT00122681) was performed to ascertain whether protection against low-risk HPV types was apparent...
  20. ncbi request reprint Cervical screening in adolescents--at least do no harm
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London EC1M 6BQ, UK
    Lancet 364:1642-4. 2004
  21. doi request reprint HPV vaccines: peering through the fog
    Anne Szarewski
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, UK
    J Fam Plann Reprod Health Care 34:207-9. 2008
  22. ncbi request reprint Cervical screening by visual inspection with acetic acid
    Anne Szarewski
    Wolfson Institute of Preventive Medicine, London EC1M 6BQ, UK
    Lancet 370:365-6. 2007